Multiple Myeloma | Unmet Need | US/EU | 2016

launch Related Market Assessment Reports

• Alopecia – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis – Alopecia Areata (US)

  March 2023

  Alopecia areata (AA) is an inflammatory autoimmune skin disease characterized by the targeting of anagen hair follicles by the host immune system, resulting in varying degrees of hair loss. Topical…

• Diabetic Nephropathy – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)

  Diabetic nephropathy (DN), also referred to as diabetic kidney disease, is a common complication of diabetes. The DN drug market comprises a wide variety of antidiabetic and antihypertensive drugs…

• Acute Myeloid Leukemia – Unmet Need – Detailed, Expanded Analysis: First-Line Intensive-Induction-Eligible Acute Myeloid Leukemia (US/EU)

  Acute myeloid leukemia (AML) is the most common acute leukemia in adults, originating from mutant myeloid precursor cells. Presently, the AML drug market is dominated by chemotherapy backbones, but…

• Nonalcoholic Steatohepatitis – Unmet Need – Detailed, Expanded Analysis (US/EU)

  For the abstract please provide an overview paragraph here and then fill in the bulleted sections below. Feel free to modify the bulleted section. Leverage content from a brochure if you have one…

• Multiple Sclerosis – Geographic Focus: China – Multiple Sclerosis: China In-Depth (China)

  March 2023

  Multiple sclerosis (MS), a chronic immune-mediated disease of the nervous system, is classified as a rare disease in China because of its low prevalence in that country. Traditionally, MS patients…